Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Potent and selective ETA antagonists from Shionogi

May 7, 1997

Cytel and Schwarz terminate research collaboration

May 6, 1997

Results from analysis of 10 years of amiodarone therapy presented

May 6, 1997

CytRx initiates new phase II trial of purified RheothRx

May 5, 1997

Lp-PLA2 inhibitors from SmithKline Beecham

May 5, 1997

Zeneca and the University of Oxford enter collaboration for genetic research into heart disease

May 2, 1997

Calcium antagonist shown to cause left ventricular hypertrophy regression

April 30, 1997

Roche discloses human renin inhibitors

April 30, 1997

Kissei prepares smooth muscle cell proliferation inhibitors

April 30, 1997

Novel cardiac antiischemic agents disclosed by Kanebo

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...